QuickView for USH2A;jsessionid=2C182DA29728D929DD6A8F6D02517B76;jsessionid=658199A28F57B4EE91BF6C86BB422988;jsessionid=5584AFB4C68F91535CB0CFF06CF52D4C (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Microglial cell
Myeloid cells of peripheral blood
Appendix
Superior cervical ganglion
Atrioventricular node

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Retinitis pigmentosa-deafness syndrome
Cholestasis
Cirrhosis of liver
Placental insufficiency
Hepatic fibrosis

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

Pyocyanine
Gallic Acid
telithromycin
triptolide
MS 27-275

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

Dux
INTS8
KLF13
NCL
TINCR

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

USH2A mutational spectrum causing syndromic and non-syndromic retinal dystrophies in a large cohort …
Generation of the induced pluripotent stem cell line SFMUi001-A from a patient with usher syndrome t…
Successful large gene augmentation of USH2A with non-viral episomal vectors.
USH2A Gene Mutations in Rabbits Lead to Progressive Retinal Degeneration and Hearing Loss.
Exome sequencing identified five novel USH2A variants in Korean patients with retinitis pigmentosa.

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for USH2A;jsessionid=2C182DA29728D929DD6A8F6D02517B76;jsessionid=658199A28F57B4EE91BF6C86BB422988;jsessionid=5584AFB4C68F91535CB0CFF06CF52D4C

Explore Clinical Trials Results